Alzheimer’s Society is partnering with the Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest. We're supporting in their upcoming AgeTech Insights Report, looking into modifiable risk factors for dementia. 

Baristas can receive more training to make great coffee than care workers receive to provide dementia care – a new report exposes alarming gaps in dementia training.

Alzheimer's Society responds to the claim that amyloid-targeting drugs show no clinically meaningful positive effects.

Alzheimer's Society welcomes the decision and says the Government must be ambitious about preparing for new treatments.

CrossSense will help people with early-stage dementia with daily activities, such as making a cup of tea and interacting with loved ones.

Alzheimer’s Society supports and invests in innovations to transform the lives of people affected by dementia. This week, we were delighted to welcome new innovators to our award-winning innovation programme.